Pharmaceutical

Laboratory Information System Market Surges to USD 3.6 Billion by 2030, Propelled by 6.5% CAGR – Verified Market Reports®

The Laboratory Information System (LIS) market is primarily driven by the increasing demand for automation in laboratory processes, which enhances…

4 months ago

Restore Hyper Wellness and MECOTEC Announce Strategic Partnership in Cryotherapy Solutions

AUSTIN, Texas and BITTERFELD-WOLFEN, Germany, Sept. 23, 2024 /PRNewswire/ -- Restore Hyper Wellness and MECOTEC are proud to announce an exciting…

4 months ago

CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum

Webcast presentation on Wednesday, September 25th at 1:55 PM CEST HOUSTON, TX / ACCESSWIRE / September 23, 2024 / CNS…

4 months ago

Perfiby Announces Innovative New Supplements to Address Wide Range of Consumer Health Issues

CALIFORNIA CITY, CA / ACCESSWIRE / September 23, 2024 / Perfidy has just released a range of new natural help…

4 months ago

Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs’ Mpox PCR Detection Kits

CHICAGO, IL / ACCESSWIRE / September 23, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

4 months ago

Science & Humans Proudly Welcomes Renowned Healthcare Leader Karim “Matt” Nassar as Chief Growth Officer

MISSISSAUGA, ON / ACCESSWIRE / September 23, 2024 / Science & Humans (S&H), Canada's leading platform for hormone health, is…

4 months ago

Interim Results for the Six Months Ended 30 June 2024

Press release OXFORD BIOMEDICA PLCINTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024 Delivering Pure-Play CDMO Growth Strategy Continued…

4 months ago

SciSparc Receives FDA Approval to Initiate Phase IIb Clinical Trial for Tourette Syndrome Treatment

FDA confirms that SciSparc’s study may proceed following the application submission a month ago TEL AVIV, Israel, Sept. 23, 2024…

4 months ago

Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology Congress

Oral and poster presentations of results from Study 501 evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for…

4 months ago

European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement

European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement Paris, France, September 23, 2024, 2:00 pm CET…

4 months ago